Free Trial

TransMedics Group (TMDX) News Today

$139.04
-4.96 (-3.44%)
(As of 06/21/2024 ET)
TransMedics Group logo with Medical background
Goldman Sachs Group Inc. Raises Stock Holdings in TransMedics Group, Inc. (NASDAQ:TMDX)
Goldman Sachs Group Inc. raised its stake in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 10.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 397,283 shares of the company's stock aft
TransMedics Group logo with Medical background
TransMedics Group (NASDAQ:TMDX) Stock Rating Reaffirmed by Piper Sandler
Piper Sandler reiterated an "overweight" rating and issued a $120.00 price objective on shares of TransMedics Group in a research report on Friday.
The 3 Best Medical Device Stocks to Buy in June 2024
TransMedics Group logo with Medical background
7,640 Shares in TransMedics Group, Inc. (NASDAQ:TMDX) Purchased by HighPoint Advisor Group LLC
HighPoint Advisor Group LLC bought a new position in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 7,640 shares of the company's stock, valued at
TransMedics Group logo with Medical background
Insider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) CEO Sells 8,625 Shares of Stock
TransMedics Group, Inc. (NASDAQ:TMDX - Get Free Report) CEO Waleed H. Hassanein sold 8,625 shares of the business's stock in a transaction on Friday, June 14th. The shares were sold at an average price of $141.85, for a total transaction of $1,223,456.25. Following the completion of the sale, the chief executive officer now directly owns 61,643 shares of the company's stock, valued at $8,744,059.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
TransMedics Group (NASDAQ:TMDX) Stock Price Up 2.8%
TransMedics Group logo with Medical background
Osterweis Capital Management Inc. Purchases 28,390 Shares of TransMedics Group, Inc. (NASDAQ:TMDX)
Osterweis Capital Management Inc. grew its position in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 78.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 64,565 shares of the company's stock after buying an additional 28,3
TransMedics Group logo with Medical background
TransMedics Group (NASDAQ:TMDX) Shares Down 2.3%
TransMedics Group (NASDAQ:TMDX) Shares Down 2.3%
TransMedics Group logo with Medical background
First Light Asset Management LLC Has $59.54 Million Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX)
First Light Asset Management LLC lifted its stake in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 22.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 754,317 shares of the company's st
TransMedics Group logo with Medical background
Bellevue Group AG Sells 17,847 Shares of TransMedics Group, Inc. (NASDAQ:TMDX)
Bellevue Group AG reduced its stake in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 3.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 518,890 shares of the company's stock
TransMedics Group logo with Medical background
TransMedics Group (NASDAQ:TMDX) Sets New 12-Month High After Analyst Upgrade
TransMedics Group (NASDAQ:TMDX) Sets New 52-Week High on Analyst Upgrade
TransMedics Group logo with Medical background
TransMedics Group (NASDAQ:TMDX) Shares Gap Up to $133.02
TransMedics Group (NASDAQ:TMDX) Shares Gap Up to $133.02
TransMedics Group logo with Medical background
TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of TransMedics Group, Inc. (NASDAQ:TMDX - Get Free Report) have been given an average rating of "Moderate Buy" by the ten ratings firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating and nine have assigned a buy rating
TransMedics Group logo with Medical background
TransMedics Group (NASDAQ:TMDX) Earns Overweight Rating from Analysts at Cantor Fitzgerald
Cantor Fitzgerald initiated coverage on shares of TransMedics Group in a research note on Thursday. They issued an "overweight" rating and a $161.00 price objective on the stock.
TransMedics Group logo with Medical background
Hsbc Holdings PLC Raises Stock Holdings in TransMedics Group, Inc. (NASDAQ:TMDX)
Hsbc Holdings PLC boosted its stake in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 19.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,650 shares of the company's stock after
TransMedics Group logo with Medical background
Insider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) CFO Sells 2,060 Shares of Stock
TransMedics Group, Inc. (NASDAQ:TMDX - Get Free Report) CFO Stephen Gordon sold 2,060 shares of the stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $135.93, for a total transaction of $280,015.80. Following the completion of the transaction, the chief financial officer now directly owns 21,299 shares of the company's stock, valued at approximately $2,895,173.07. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
TransMedics Group logo with Medical background
TransMedics Group (NASDAQ:TMDX) Shares Up 3.7%
TransMedics Group (NASDAQ:TMDX) Trading Up 3.7%
TransMedics Group logo with Medical background
TransMedics Group (NASDAQ:TMDX) Earns Overweight Rating from Analysts at Stephens
Stephens initiated coverage on shares of TransMedics Group in a research report on Tuesday. They set an "overweight" rating and a $151.00 price objective for the company.
TransMedics Group logo with Medical background
Alberta Investment Management Corp Sells 6,137 Shares of TransMedics Group, Inc. (NASDAQ:TMDX)
Alberta Investment Management Corp cut its holdings in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 30.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,752 shares of the company's stock after selling 6,137
TransMedics Group logo with Medical background
Alpha DNA Investment Management LLC Invests $500,000 in TransMedics Group, Inc. (NASDAQ:TMDX)
Alpha DNA Investment Management LLC bought a new position in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 6,337 shares of the company's stock, valued at approximately $
TransMedics Group logo with Medical background
Axiom Investors LLC DE Has $6.61 Million Position in TransMedics Group, Inc. (NASDAQ:TMDX)
Axiom Investors LLC DE lifted its holdings in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 83.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 83,750 shares of the company's stock after
TransMedics Group logo with Medical background
TransMedics Group, Inc. (NASDAQ:TMDX) Director Sells $168,988.45 in Stock
TransMedics Group, Inc. (NASDAQ:TMDX - Get Free Report) Director David Weill sold 1,193 shares of the company's stock in a transaction that occurred on Wednesday, May 29th. The shares were sold at an average price of $141.65, for a total value of $168,988.45. Following the completion of the sale, the director now owns 10,732 shares of the company's stock, valued at $1,520,187.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
TransMedics Group logo with Medical background
BNP Paribas Financial Markets Sells 12,014 Shares of TransMedics Group, Inc. (NASDAQ:TMDX)
BNP Paribas Financial Markets lowered its position in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 48.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 12,872 shares of the company's stock after
TransMedics Group logo with Medical background
TransMedics Group (NASDAQ:TMDX) Hits New 52-Week High at $143.46
TransMedics Group (NASDAQ:TMDX) Reaches New 12-Month High at $143.46
TransMedics Group logo with Medical background
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by Victory Capital Management Inc.
Victory Capital Management Inc. trimmed its position in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 59.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,239 shares of the compan
Jump Financial LLC Reduces Position in TransMedics Group, Inc. (NASDAQ:TMDX)
Jump Financial LLC trimmed its stake in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 91.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,300 shares of the company's stock after selling 70,459
Dynamic Technology Lab Private Ltd Invests $889,000 in TransMedics Group, Inc. (NASDAQ:TMDX)
Dynamic Technology Lab Private Ltd purchased a new stake in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 11,263 shares of the company's stock, valued at approximately $8
TransMedics: Transportation Supporting Growth
TransMedics Group (NASDAQ:TMDX) Sets New 1-Year High at $140.26
TransMedics Group (NASDAQ:TMDX) Sets New 52-Week High at $140.26
Swiss National Bank Trims Stock Holdings in TransMedics Group, Inc. (NASDAQ:TMDX)
Swiss National Bank lessened its holdings in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 10.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 64,300 shares of the compa
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by Nicholas Investment Partners LP
Nicholas Investment Partners LP trimmed its position in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 85.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 58,498 shares o
TransMedics Group (NASDAQ:TMDX) Sets New 52-Week High at $137.22
TransMedics Group (NASDAQ:TMDX) Reaches New 52-Week High at $137.22
Insider Selling: TransMedics Group, Inc. (NASDAQ:TMDX) Director Sells 12,025 Shares of Stock
TransMedics Group, Inc. (NASDAQ:TMDX - Get Free Report) Director James R. Tobin sold 12,025 shares of TransMedics Group stock in a transaction on Friday, May 3rd. The stock was sold at an average price of $125.05, for a total transaction of $1,503,726.25. Following the completion of the sale, the director now owns 193,146 shares of the company's stock, valued at approximately $24,152,907.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
TransMedics Group (NASDAQ:TMDX) Reaches New 52-Week High at $132.96
TransMedics Group (NASDAQ:TMDX) Reaches New 1-Year High at $132.96
Lisanti Capital Growth LLC Takes Position in TransMedics Group, Inc. (NASDAQ:TMDX)
Lisanti Capital Growth LLC acquired a new position in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 109,435 shares of the company's st
Get TransMedics Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMDX and its competitors with MarketBeat's FREE daily newsletter.

Who are Nvidia’s Silent Partners? (Ad)

Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.

I call these Nvidia’s “Silent Partners.”

TMDX Media Mentions By Week

TMDX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TMDX
News Sentiment

0.66

0.71

Average
Medical
News Sentiment

TMDX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TMDX Articles
This Week

12

5

TMDX Articles
Average Week

Get TransMedics Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMDX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:TMDX) was last updated on 6/23/2024 by MarketBeat.com Staff

From Our Partners